Outcome |  >  = 35% increase PA T2 N = 35 |  < 35% increase PA T2 N = 38 | Model A N = 71 |  |  | Model B N = 71 |  |  |
---|---|---|---|---|---|---|---|---|
Serum concentrations | Mean (sd) | Mean (sd) | B (95% CI) | P value | d | B (95% CI) | P value | d |
IGF-I | ||||||||
 Baseline | 14.55 (3.79) | 13.87 (4.43) |  |  |  |  |  |  |
 6 months | 15.27 (3.80) | 14.55 (3.79) |  − 0.25 (− 0.85 to 0.35) | .41a | .06 |  − 0.31 (− 0.98 to 0.34) | .35a | .07 |
Insulin | ||||||||
 Baseline | 53.84 (39.21) | 51.93 (36.92) |  |  |  |  |  |  |
 6 months | 46.36 (46.01) | 44.89 (22.09) | 1.66 (− 3.74 to 7.05) | .55 | .04 | 1.57 (− 4.33 to 7.48) | .60 | .04 |
Total cholesterol | ||||||||
 Baseline | 5.47 (1.25) | 5.19 (1.15) |  |  |  |  |  |  |
 6 months | 5.58 (1.12) | 5.18 (1.08) | 0.02 (− 0.10 to 0.14) | .72 | .02 | 0.03 (− 0.10 to 0.16) | .65 | .03 |
HDL-cholesterol | ||||||||
 Baseline | 1.41 (0.44) | 1.45 (0.39) |  |  |  |  |  |  |
 6 months | 1.50 (0.44) | 1.45 (0.39) | 0.02 (− 0.02 to 0.06) | .38 | .05 | 0.02 (− 0.02 to 0.07) | .34 | .05 |
Triglycerides | ||||||||
 Baseline | 1.43 (0.66) | 1.62 (1.25) |  |  |  |  |  |  |
 6 months | 1.40 (0.74) | 1.63 (0.96) | 0.001 (− 0.13 to 0.13) | .99 | 0 |  − 0.02 (− 0.16 to 0.12) | .76 | .02 |